IN2C Decision supports cosmetic brands, ingredient manufacturers and investors at the intersection of scientific R&D expertise and business strategy. We turn technical complexity into a competitive edge.
IN2C Decision advises cosmetic and nutraceutical companies, investment funds and ingredient manufacturers on high-stakes decisions where scientific expertise determines value: M&A due diligence, active sourcing, clean beauty positioning, innovation strategy and regulatory arbitration.
The firm is founded by Hichem Henchiri, PhD in Phytochemistry (Muséum National d'Histoire Naturelle, Paris) and a graduate of the ESSEC Master in Strategy & International Business. Over fifteen years in R&D within Naturex (now Givaudan Active Beauty) and Solabia, two world-leading natural ingredient groups, before taking the position of R&D, Innovation & Quality Director at Arboretum Ingredients, where the patented Ultrasevum™ technology was developed.
From this trajectory emerged a rare dual perspective: the technical mastery of natural active development — plant extraction, analytical methods, stability and efficacy studies, regulatory compliance — combined with the strategic lens that turns science into competitive advantage.
This dual expertise informs consequential decisions: validating an acquisition target, qualifying a sourcing partner, securing a clean beauty claim, anticipating market dynamics across Europe, China and the Middle East.
In-depth market analyses, competitive mapping, opportunity identification and trend monitoring across cosmetics and nutraceuticals.
Scientific and strategic assessment of acquisition, partnership or investment targets. Decoding technical claims with an expert eye.
Scientific guidance on active ingredient development, extraction technology selection, formulation and IP strategy.
Regulatory support, technical dossier structuring, positioning strategy and launch on target markets (EU, US, Asia).
Sharp understanding of your stake: investment decision, technology choice, market opportunity. Tight study perimeter and actionable deliverables defined upfront.
Scientific analyses, literature search, patent review, expert interviews, competitive intelligence. Combining hard technical groundwork with field insight.
Structured deliverables: clear reports, decision matrices, opportunity scoring. A business reading of scientific facts, no unnecessary jargon.
A clear, argued position: go / no-go, prioritisation, scenarios. Implementation support if relevant. You walk away with a decision, not just slides.
An informed decision beats a comfortable consensus. Our role is to ask the right scientific questions before financial pressure makes them inaudible.
An acquisition to assess, an ingredient to validate, a market to decode, a technology to benchmark? An initial discussion, with no commitment, helps frame the mission precisely and shape a tailored approach.